A recent study published in PLoS Medicine examined the pain-related and treatment outcomes of Medicare patients with opioid use disorder (OUD) and comorbid chronic pain who initiated treatment with either methadone or buprenorphine. The retrospective cohort study utilized 100% Medicare data from 2020 to 2023, focusing on 49,727 eligible patients. The findings revealed that methadone, administered at opioid treatment programs, was associated with significantly lower rates of pain-related hospitalizations and emergency department visits compared to buprenorphine, which is primarily prescribed in office-based settings. Specifically, the incidence rate ratios indicated a 36% reduction in hospitalization and a 13% reduction in emergency visits for those on methadone.
Despite these favorable pain-related outcomes, the study found no significant differences in opioid overdose rates or all-cause mortality between the two treatment groups. The adjusted risk differences showed that while methadone reduced hospitalizations and emergency visits, it did not impact overdose or mortality rates within the first year of treatment initiation. The study's limitations include potential unmeasured confounders and the generalizability of results, as the findings are specific to Medicare patients with chronic pain receiving treatment for OUD.
These results underscore the importance of considering treatment settings and patient populations when evaluating the effectiveness of OUD therapies. The authors caution that the observed differences may reflect variations in patient characteristics, treatment practices, and pharmacological effects that warrant further investigation. As the opioid crisis continues to evolve, understanding the nuances of treatment outcomes for patients with comorbid conditions remains critical for healthcare providers and policymakers.
PLOS Medicine · Mar 26In a recent commentary published in multiple journals, including JAMA and PLOS Medicine, experts emphasize the urgent need for a responsible authorship culture in scientific research. Authorship practices have come under scrutiny due to concerns about integrity, as questionable practices can undermine trust in research findings. The authors, including journal editors and researchers, highlight that traditional authorship criteria often overlook critical contributions from individuals involved in data integrity and methodology, particularly those outside academia.
The working group convened by the US National Academies of Sciences, Engineering, and Medicine identified three interconnected principles essential for fostering a responsible authorship culture: credit, accountability, and transparency. Their analysis revealed that while some US institutions have public authorship guidelines, there is significant room for improvement, and these issues are not confined to the United States but are global in nature.
Institutions play a pivotal role in shaping authorship standards through the incentives they provide, and the authors call for a collective effort to establish better practices. Journals are also urged to enhance their guidance on authorship, as current standards are often inadequate for modern research challenges. The authors commit to revisiting and supporting a fair authorship culture, advocating for the adoption of the credit-accountability-transparency framework as a means to improve practices across the board.
This initiative aims to ensure that all contributors to research are recognized appropriately, thereby enhancing the integrity and trustworthiness of scientific literature. The commentary serves as a rallying cry for institutions, journals, and the broader research community to engage in this critical dialogue and implement necessary changes.
PLOS Medicine · Mar 26A recent study published in PLoS Medicine has provided significant insights into the relationship between physical activity and mortality outcomes among mid-aged Australian women. Utilizing a target trial emulation framework, researchers analyzed data from 11,169 women participating in the Australian Longitudinal Study on Women’s Health (ALSWH) over a 15-year period. The study aimed to compare the effects of consistent adherence to the World Health Organization's (WHO) recommendations for moderate-to-vigorous physical activity (MVPA) against non-adherence, focusing on all-cause mortality, cardiovascular disease (CVD), and cancer mortality.
The findings revealed that women who consistently met the WHO's MVPA guidelines of at least 150 minutes per week exhibited a 50% reduction in all-cause mortality risk compared to those who did not adhere to these recommendations. This protective effect was statistically significant, with a risk ratio of 0.50 and a risk difference of -5.2%. However, the results for CVD and cancer mortality were less conclusive, indicating a need for further research to clarify these associations.
The study's implications are critical for public health, suggesting that promoting regular physical activity among mid-aged women could lead to substantial reductions in premature mortality. Despite the promising results, the authors noted limitations, including reliance on self-reported physical activity data and potential generalizability issues. The researchers advocate for continued encouragement of physical activity adherence throughout mid-life to maximize health benefits.
As the study highlights the importance of sustained physical activity, healthcare professionals are urged to integrate these findings into patient care strategies, emphasizing the long-term health benefits of an active lifestyle. Future research should aim to explore the causal mechanisms behind these associations and assess the impact of initiating physical activity later in life.
PLOS Medicine · Mar 26